Prelude Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-126
| Closed | -$9K | – | 1232 |
|
|
2019
Q1 | $9K | Buy |
+126
| New | +$9K | ﹤0.01% | 1077 |
|
|
2016
Q4 | – | Sell |
-1,858
| Closed | -$123K | – | 1478 |
|
|
2016
Q3 | $123K | Buy |
1,858
+284
| +18% | +$18.8K | 0.01% | 692 |
|
|
2016
Q2 | $88K | Buy |
+1,574
| New | +$88K | 0.01% | 763 |
|
|
2016
Q1 | – | Sell |
-1,200
| Closed | -$54K | – | 1162 |
|
|
2015
Q4 | $54K | Buy |
+1,200
| New | +$54K | 0.01% | 963 |
|
|
2015
Q3 | – | Sell |
-1,100
| Closed | -$68K | – | 1367 |
|
|
2015
Q2 | $68K | Buy |
1,100
+400
| +57% | +$24.7K | 0.01% | 963 |
|
|
2015
Q1 | $44K | Sell |
700
-700
| -50% | -$44K | 0.01% | 1303 |
|
|
2014
Q4 | $79K | Sell |
1,400
-6,300
| -82% | -$356K | 0.01% | 1017 |
|
|
2014
Q3 | $218K | Buy |
7,700
+6,351
| +471% | +$180K | 0.03% | 620 |
|
|
2014
Q2 | $46K | Sell |
1,349
-800
| -37% | -$27.3K | 0.01% | 1236 |
|
|
2014
Q1 | $67K | Buy |
+2,149
| New | +$67K | 0.01% | 1036 |
|